Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
eczema outbreak; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (eczema outbreak) in an 83-year-old patient of an unknown gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Eczema. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced ECZEMA (eczema outbreak). At the time of the report, ECZEMA (eczema outbreak) had resolved. No concomitant medication was reported. Although each time patient got a booster, experienced eczema outbreak for about a month. Patient asked guidance on receiving new vaccine given tolerability of eczema versus risk of COVID. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2025-790141 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790141:Same patient with different suspect (Moderna COVID-19 Vaccine)
Eczema